Chart calendar Cerevel Therapeutics Holdings, Inc.

e675ed9f8175a5416b0ae.lHKr4kgrXmiTVpA9fguxA886Jt7uyet1uJnOPuU88dQ.pAfKiQ1JGDerH_EFNHLCZqFMH5WBkLEv9MiiE9d1wLz4AN2YIxINMtAO-w~5a92dbc5313a978d4afbf76fc4e80986

Upcoming events on Cerevel Therapeutics Holdings, Inc.

29/07/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Cerevel Therapeutics Holdings, Inc.

16/02/2024 14:00 Extraordinary Shareholders Meeting
30/11/2023 14:10 Evercore ISI HealthCONx Conference
14/11/2023 09:00 Jefferies London Healthcare Conference
01/11/2023 12:00 Q3 2023 Earnings Call
01/11/2023 10:30 Q3 2023 Earnings Release
12/09/2023 14:30 Morgan Stanley Global Healthcare Conference - Fireside Chat
02/08/2023 13:00 Q2 2023 Earnings Call
02/08/2023 11:30 Q2 2023 Earnings Release
07/06/2023 14:00 Annual General Meeting
10/05/2023 18:00 Bank of America Healthcare Conference
03/05/2023 13:00 Q1 2023 Earnings Call
03/05/2023 11:30 Q1 2023 Earnings Release
29/03/2023 15:30 Stifel CNS Day
06/03/2023 14:10 Cowen Health Care Conference
22/02/2023 13:00 FY 2022 Earnings Call
22/02/2023 11:30 FY 2022 Earnings Release
10/01/2023 16:15 JP Morgan Healthcare Conference
29/11/2022 20:30 Evercore ISI HealthCONx Conference
16/11/2022 20:00 Stifel Healthcare Conference
14/11/2022 Guggenheim Healthcare Talks Immunology & Neurology Day

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


67,2

EBITDA
Million USD
Released
Forecast
Spread
-217
-207
-5.1%
-363
-349
-4.11%
-442
-417
-5.92%

-464


-557


-544

EBIT
Million USD
Released
Forecast
Spread
-220
-211
-4.33%
-368
-358
-2.78%
-447
-421
-6.3%

-504


-565


-564

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-225
-222
-1.41%
-351
-356
1.27%
-432
-404
-7.02%

-402


-548


-539

Net income
Million USD
Released
Forecast
Spread
-225
-222
-1.38%
-352
-356
1.14%
-433
-405
-6.9%

-472


-561


-562

EPS
USD
Released
Forecast
Spread
-1,65
-1,61
-2.37%
-2,32
-2,35
1.1%
-2,67
-2,50
-6.61%

-2,61


-2,88


-2,69

Announcement Date01/03/2222/02/2327/02/24-

Quarterly results

Fiscal PeriodMarch 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread



-93,8
-93,3
-0.53%
-106
-94,4
-12.24%






-110
-104
-5.27%
-138
-108
-27.83%
























EBIT
Million USD
Released
Forecast
Spread
-93,0
-70,9
-31.1%
-95,1
-93,3
-1.86%
-107
-100
-6.89%
-99,6
-109
8.39%
-96,8
-109
10.84%
-111
-103
-7.61%
-140
-113
-23.37%
-143
-119
-19.46%

-133


-135


-137


-125


-128


-134


-137

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-90,5
-74,1
-22.15%
-99,9
-94,7
-5.55%
-92,6
-98,1
5.54%
-104
-110
5.61%
-99,4
-111
10.17%
-96,2
-103
6.56%
-132
-104
-27.18%
-132
-110
-19.62%

-81,9


-81,9


-67,3


-123


-126


-132


-135

Net income
Million USD
Released
Forecast
Spread
-90,5
-74,4
-21.58%
-99,9
-96,0
-4.1%
-92,8
-97,5
4.83%
-104
-106
1.61%
-99,5
-109
8.9%
-96,4
-102
5.78%
-133
-105
-26.66%
-132
-110
-19.75%

-116


-117


-127


-123


-126


-132


-135

EPS
USD
Released
Forecast
Spread
-0,61
-0,48
-27.88%
-0,66
-0,62
-6.48%
-0,59
-0,62
5.45%
-0,67
-0,67
0.72%
-0,63
-0,69
8.32%
-0,61
-0,65
5.83%
-0,76
-0,60
-26.62%
-0,73
-0,61
-19.39%

-0,64


-0,65


-0,67


-0,72


-0,73


-0,76


-0,78

Announcement Date01/08/2208/11/2222/02/2303/05/2302/08/2301/11/2327/02/2408/05/24-------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CERE Stock
  4. Calendar Cerevel Therapeutics Holdings, Inc.